Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
451-465 of 2993 results
MetaStat announces successful analytical validation of its MenaCalc cancer diagnostic platform
By MDBR Staff Writer
MetaStat, a molecular diagnostic company, announced the successful completion of an analytical validation study of its MenaCalc clinical test, which demonstrated strong overall assay performance and precision with mean coefficient of variation (%CV) of only 2.3% (Range 0.07-6.95).
Diagnostics > In Vitro Diagnostics > News
PerkinElmer buys Sweden’s Vanadis Diagnostics
By MDBR Staff Writer
PerkinElmer has completed the acquisition of Sweden-based Vanadis Diagnostics, for an undisclosed sum.
Diagnostics > In Vitro Diagnostics > News
Quest Diagnostics expands Dako's PD-L1 IHC 28-8 complementary test to include melanoma
By MDBR Staff Writer
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific launches new B•R•A•H•M•S PCT testing solution in Europe for Samsung IB10 point-of-care platform
By MDBR Staff Writer
For healthcare professionals facing the complexity of daily requirements in emergency situations, a new point-of-care test, Samsung IB B•R•A•H•M•S PCT assay, offers an integrated solution for accurate sepsis diagnosis and antibiotic stewardship.
Diagnostics > In Vitro Diagnostics > News
Exosome Diagnostics introduces new RNA-based liquid biopsy test
By MDBR Staff Writer
Exosome Diagnostics has introduced new liquid biopsy test ExoDx Lung(ALK), developed to isolate and analyze exosomal RNA (exoRNA) from a blood sample.
Diagnostics > In Vitro Diagnostics > News
Amarantus to merge diagnostic business with Avant
By MDBR Staff Writer
Amarantus Bioscience Holdings has agreed to merge its wholly-owned subsidiary Amarantus Diagnostics into medical diagnostic technology firm Avant Diagnostics.
Diagnostics > In Vitro Diagnostics > News
FDA clears Siemens’ new high-volume coagulation analyzer
Siemens Healthcare announces the FDA 510(k) clearance of the globally proven Sysmex CS-5100 System. This hemostasis system was the first to market with PSI technology globally and is now available to Siemens’ U.S. customers.
Diagnostics > In Vitro Diagnostics > News
SGI-DNA launches automated cloning module for BioXp 3200 system
SGI-DNA, a Synthetic Genomics, Inc. (SGI) company, announced today that the world's first DNA printer, the BioXp™ 3200 System, has reached another milestone with the release of the BioXp™ cloning module.
Diagnostics > In Vitro Diagnostics > News
Philips and Banyan Biomarkers partner to develop new handheld blood test
By MDBR Staff Writer
Royal Philips and Banyan Biomarkers announced that they have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care. The new handheld test will be based on Philips’ Minicare I-20 system.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific to acquire Affymetrix for $1.3bn
By MDBR Staff Writer
Thermo Fisher Scientific has agreed to acquire cellular and genetic analysis products provider Affymetrix, for around $1.3bn.
Diagnostics > In Vitro Diagnostics > News
Sinocare Group closes acquisition of Nipro Diagnostics
By MDBR Staff Writer
Nipro Diagnostics announced that its acquisition by Sinocare Group has been completed. The company also announced that with completion of the acquisition, the company has been renamed Trividia Health.
Diagnostics > In Vitro Diagnostics > News
Merck and Biocartis to develop new liquid biopsy RAS biomarker test
By MDBR Staff Writer
Molecular diagnostics firm Biocartis has entered into a collaboration agreement with Merck to develop and commercialize new liquid biopsy RAS biomarker test to treat patients with metastatic colorectal cancer (mCRC).
Diagnostics > In Vitro Diagnostics > News
Cepheid announces distribution agreement with Henry Schein
By MDBR Staff Writer
Cepheid announced an agreement with Henry Schein Medical, the US medical business of Henry Schein, for the distribution of its GeneXpert System and menu of 17 Xpert tests spanning healthcare associated infections, critical infectious disease, and sexual health.
Diagnostics > In Vitro Diagnostics > News
ABMC launches new rapid drug test for K2
By MDBR Staff Writer
American Bio Medica Corporation (ABMC) announced that they have completed the research and development of a new rapid urine drug test that will detect compounds found in synthetic marijuana; commonly known as “K2”or “Spice”.
Diagnostics > In Vitro Diagnostics > News
NeoGenomics completes acquisition of GE Healthcare's Clarient for $275m
By MDBR Staff Writer
Genetic testing services provider NeoGenomics has completed the acquisition of GE Healthcare's Life Sciences business unit Clarient and its wholly-owned subsidiary Clarient Diagnostic Services, for around $275m.
Diagnostics > In Vitro Diagnostics > News
451-465 of 2993 results